0.6006 USD
0 (-0.79%)
0.6099 USD
+0.01 (+1.55%)
NXL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for NXL as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, NXL is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- NXL had negative earnings in the past year.
- In the past year NXL has reported a negative cash flow from operations.
- In the past 5 years NXL always reported negative net income.
- In the past 5 years NXL always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of NXL (-169.31%) is worse than 88.04% of its industry peers.
- NXL has a Return On Equity of -182.01%. This is in the lower half of the industry: NXL underperforms 70.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -169.31% | ||
| ROE | -182.01% | ||
| ROIC | N/A |
ROA(3y)-110.33%
ROA(5y)-801.91%
ROE(3y)-127.63%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- NXL has a better Gross Margin (69.55%) than 78.26% of its industry peers.
- NXL's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for NXL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.55% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.73%
GM growth 5Y2.21%
2. Health
2.1 Basic Checks
- NXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
- NXL has more shares outstanding than it did 1 year ago.
- NXL has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for NXL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- NXL has an Altman-Z score of -10.54. This is a bad value and indicates that NXL is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -10.54, NXL is not doing good in the industry: 78.80% of the companies in the same industry are doing better.
- NXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -10.54 |
ROIC/WACCN/A
WACC10.02%
2.3 Liquidity
- NXL has a Current Ratio of 13.48. This indicates that NXL is financially healthy and has no problem in meeting its short term obligations.
- NXL has a Current ratio of 13.48. This is amongst the best in the industry. NXL outperforms 97.28% of its industry peers.
- A Quick Ratio of 13.03 indicates that NXL has no problem at all paying its short term obligations.
- NXL has a better Quick ratio (13.03) than 97.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.48 | ||
| Quick Ratio | 13.03 |
3. Growth
3.1 Past
- NXL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.33%.
- The Revenue has decreased by -3.09% in the past year.
- Measured over the past years, NXL shows a decrease in Revenue. The Revenue has been decreasing by -4.05% on average per year.
EPS 1Y (TTM)0.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)-3.09%
Revenue growth 3Y5.39%
Revenue growth 5Y-4.05%
Sales Q2Q%-49.58%
3.2 Future
- NXL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.65% yearly.
- NXL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 95.89% yearly.
EPS Next Y19.67%
EPS Next 2Y16.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.3%
Revenue Next 2Y95.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- NXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- NXL's earnings are expected to grow with 16.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.65%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- NXL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NEXALIN TECHNOLOGY INC / NXL FAQ
Can you provide the ChartMill fundamental rating for NEXALIN TECHNOLOGY INC?
ChartMill assigns a fundamental rating of 3 / 10 to NXL.
Can you provide the valuation status for NEXALIN TECHNOLOGY INC?
ChartMill assigns a valuation rating of 0 / 10 to NEXALIN TECHNOLOGY INC (NXL). This can be considered as Overvalued.
How profitable is NEXALIN TECHNOLOGY INC (NXL) stock?
NEXALIN TECHNOLOGY INC (NXL) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for NXL stock?
The Earnings per Share (EPS) of NEXALIN TECHNOLOGY INC (NXL) is expected to grow by 19.67% in the next year.